Key Market Indicators
Sales of Czech analgesic medicines are projected to reach $131.6 million by 2026, up from $123 million in 2021. This represents a yearly growth rate of about 1.4%. Since 1995, the Czech market has seen an average growth of 6% each year. In 2021, the country ranked 13th in terms of sales, behind Denmark's $123 million. Spain, Canada and Italy completed the top four list, coming in second, third and fourth respectively.